STAT Plus: What we learned about the business of telemedicine from Amwell and GoodRx’s IPO filings

The filings offer a window into the finances of telemedicine. Among the takeaways: Revenues aren't growing as quickly as use, and Teladoc is still on top.

Click to view original post